Doses survival time. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Cell Line, Tumor Cells, Cultured Spleen Tumor Cells, Cultured Liver Bile Ducts, Intrahepatic Cell Line Lung Brain Kidney Lymph Nodes T-Lymphocytes Bone Marrow

Organisms14

Mice, Inbred BALB C Mice, Inbred C57BL Mice, Nude Mice, Inbred Strains Rats, Sprague-Dawley Mice, Knockout Dogs Rats, Inbred F344 Mice, Transgenic Mice, SCID Mice, Inbred C3H Mice, Inbred DBA Mice, Inbred ICR Rats, Wistar

Diseases57

Lung Neoplasms Brain Neoplasms Adenocarcinoma Neoplasm Recurrence, Local Liver Neoplasms Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Disease Progression Breast Neoplasms Disease Models, Animal Glioblastoma Colorectal Neoplasms Carcinoma, Hepatocellular Pancreatic Neoplasms Neoplasms Stomach Neoplasms Carcinoma, Squamous Cell Lymphatic Metastasis Glioma Carcinoma Ovarian Neoplasms Recurrence Melanoma Neoplasm Invasiveness Bile Duct Neoplasms Carcinoma, Small Cell Esophageal Neoplasms Supratentorial Neoplasms Kidney Neoplasms Bone Neoplasms Neoplasms, Experimental Cholangiocarcinoma Leukemia L1210 Prostatic Neoplasms Pleural Neoplasms Dog Diseases Carcinoma, Renal Cell Neutropenia Mesothelioma Colonic Neoplasms Multiple Myeloma Peritoneal Neoplasms Skin Neoplasms Lymphoma Astrocytoma Postoperative Complications Head and Neck Neoplasms Rectal Neoplasms Body Weight Thrombocytopenia Leukopenia Osteosarcoma Acute Disease Lymphoma, Non-Hodgkin Sarcoma Leukemia, Experimental Kidney Failure, Chronic

Chemicals and Drugs48

Antineoplastic Agents Cisplatin Fluorouracil Tumor Markers, Biological Doxorubicin Cyclophosphamide Deoxycytidine Antimetabolites, Antineoplastic Paclitaxel Vincristine Antibodies, Monoclonal Etoposide Camptothecin Antineoplastic Agents, Phytogenic Carboplatin Leucovorin Nimustine Organoplatinum Compounds Dacarbazine Taxoids Antineoplastic Agents, Alkylating Immunosuppressive Agents Prednisone Vinblastine Methotrexate RNA, Messenger Recombinant Proteins Antibodies, Monoclonal, Humanized Drug Combinations Tegafur Oxonic Acid Neoplasm Proteins Oxyquinoline Cytarabine Antibiotics, Antineoplastic Tumor Suppressor Protein p53 Vindesine Proto-Oncogene Proteins Quinazolines Epirubicin Mitomycin Carmustine Radiation-Sensitizing Agents Ki-67 Antigen Survival of Motor Neuron 1 Protein Cytokines Pyrimidines Lomustine

Analytical, Diagnostic and Therapeutic Techniques and Equipment96

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Kaplan-Meier Estimate Prognosis Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Neoplasm Staging Combined Modality Therapy Proportional Hazards Models Follow-Up Studies Drug Administration Schedule Immunohistochemistry Multivariate Analysis Lethal Dose 50 Prospective Studies Radiotherapy Dosage Disease Models, Animal Administration, Oral Infusions, Intravenous Dose Fractionation Risk Factors Radiation Dosage Cohort Studies Neoplasm Transplantation Chemotherapy, Adjuvant Transplantation, Homologous Dose-Response Relationship, Radiation Palliative Care Remission Induction Predictive Value of Tests Risk Assessment Injections, Intravenous Skin Transplantation Radiotherapy, Adjuvant Analysis of Variance Neoplasms, Experimental Drug Therapy, Combination Injections, Intraperitoneal Heart Transplantation Reverse Transcriptase Polymerase Chain Reaction Clinical Trials as Topic Radiotherapy Actuarial Analysis Life Tables Registries Chemoembolization, Therapeutic Salvage Therapy Liver Transplantation Radiometry Random Allocation Tumor Burden Xenograft Model Antitumor Assays Double-Blind Method Blotting, Western Probability Models, Biological Transplantation, Heterologous Gene Expression Profiling Kidney Transplantation Neoplasm Grading Treatment Failure Area Under Curve Chemoradiotherapy Injections, Subcutaneous Hepatectomy Drug Evaluation Cranial Irradiation Incidence Karnofsky Performance Status Immunotherapy Regression Analysis Neoadjuvant Therapy Chi-Square Distribution Tomography, X-Ray Computed Randomized Controlled Trials as Topic Infusions, Intra-Arterial Body Weight Corneal Transplantation Severity of Illness Index Cause of Death Models, Statistical Gastrectomy Statistics, Nonparametric Tissue Array Analysis Immunoenzyme Techniques SEER Program Oligonucleotide Array Sequence Analysis Life Expectancy Genetic Therapy Clinical Trials, Phase III as Topic Whole-Body Irradiation Feasibility Studies Leukemia, Experimental Biostatistics

Phenomena and Processes27

Cell Survival Graft Survival Time Factors Apoptosis Lethal Dose 50 Radiation Dosage Graft Rejection Dose-Response Relationship, Radiation Signal Transduction Cell Proliferation Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Mutation Drug Resistance, Neoplasm Probability Cell Division Drug Synergism Longevity Area Under Curve Chi-Square Distribution Body Weight Cell Death Gene Expression Phenotype Cell Differentiation Genotype Up-Regulation

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Life Tables Registries Incidence Cause of Death SEER Program Life Expectancy

Named Groups1

Health Care42

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Proportional Hazards Models Follow-Up Studies Multivariate Analysis Prospective Studies Risk Factors Radiation Dosage Cohort Studies Age Factors Dose-Response Relationship, Radiation Palliative Care Predictive Value of Tests Risk Assessment Analysis of Variance Clinical Trials as Topic Actuarial Analysis Life Tables Registries Random Allocation Double-Blind Method Probability Treatment Failure Area Under Curve Incidence Karnofsky Performance Status Regression Analysis Chi-Square Distribution Randomized Controlled Trials as Topic Severity of Illness Index Cause of Death Models, Statistical Statistics, Nonparametric Sex Factors SEER Program Life Expectancy Clinical Trials, Phase III as Topic Feasibility Studies

Geographicals2

Japan United States

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care

Survival Rate Cell Survival Survival Analysis Disease-Free Survival Survival Treatment Outcome Graft Survival Time Factors Kaplan-Meier Estimate Prognosis Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Neoplasm Staging Lung Neoplasms Combined Modality Therapy Proportional Hazards Models Follow-Up Studies Antineoplastic Agents Drug Administration Schedule Cisplatin Brain Neoplasms Adenocarcinoma Neoplasm Recurrence, Local Liver Neoplasms Neoplasm Metastasis Fluorouracil Carcinoma, Non-Small-Cell Lung Tumor Markers, Biological Immunohistochemistry Apoptosis Multivariate Analysis Lethal Dose 50 Disease Progression Breast Neoplasms Cell Line, Tumor Prospective Studies Radiotherapy Dosage Mice, Inbred BALB C Doxorubicin Cyclophosphamide Deoxycytidine Disease Models, Animal Administration, Oral Infusions, Intravenous Glioblastoma Colorectal Neoplasms Carcinoma, Hepatocellular Antimetabolites, Antineoplastic Dose Fractionation Risk Factors Radiation Dosage Pancreatic Neoplasms Mice, Inbred C57BL Neoplasms Stomach Neoplasms Cohort Studies Carcinoma, Squamous Cell Paclitaxel Lymphatic Metastasis Neoplasm Transplantation Chemotherapy, Adjuvant Glioma Transplantation, Homologous Age Factors Graft Rejection Carcinoma Ovarian Neoplasms Dose-Response Relationship, Radiation Vincristine Antibodies, Monoclonal Signal Transduction Cell Proliferation Palliative Care Remission Induction Etoposide Predictive Value of Tests Recurrence Camptothecin Antineoplastic Agents, Phytogenic Melanoma Carboplatin Leucovorin Gene Expression Regulation, Neoplastic Risk Assessment Nimustine Cells, Cultured Injections, Intravenous Skin Transplantation Dose-Response Relationship, Drug Organoplatinum Compounds Mice, Nude Neoplasm Invasiveness Bile Duct Neoplasms Dacarbazine Carcinoma, Small Cell Taxoids Esophageal Neoplasms Radiotherapy, Adjuvant Analysis of Variance Mutation

No FAQ available that match "doses survival time"